Trial
NCT01076400
A Study of Adavosertib (MK-1775) in Combination With Topotecan/Cisplatin in Participants With Cervical Cancer (MK-1775-008)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Merck Sharp & Dohme LLC
Collaborators
—
Condition
Cervical Cancer
Intervention
adavosertib
Why stopped
The sponsor permanently suspended new enrollment into the trial and discontinued the study; which was not related to any concerns over product safety.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-18